Patient-first trial design, based around the tenets of adaptability and personalization, has emerged as a key solution to increase diversity and improve trial outcomes for all.
Sam Whitaker and Jason Dong
Advertisement
Articles by Sam Whitaker and Jason Dong
Advertisement
Latest Updated Articles
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
